-transparent.png){kind=logo}
In this study the pharmacokinetics of a new slow-release formulation of bezafibrate (a hypolipaemic drug) were evaluated in a group of six healthy volunteers. In the first part of the study the bioavailability of this formulation was compared to the normal preparation of bezafibrate. In the second part of the experiment the possible accumulation was studied. The subjects were administered the slow-release preparation at 08h00 for seven consecutive days. The resulting data indicate that the slow-release formulation shows a lower dispersion of Tmax values. There was an increase of the plasma half-life from 1.9 to 5.5 h, but a possibility of accumulation could be excluded.
Related Publications
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
August 1982,
British journal of clinical pharmacology,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
August 1990,
Acta neurologica Scandinavica,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
January 1983,
Arzneimittel-Forschung,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
January 1989,
Neuropsychobiology,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
October 1981,
British journal of clinical pharmacology,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
January 1978,
Therapie,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
October 1994,
Journal of clinical pharmacy and therapeutics,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
July 1973,
International journal of clinical pharmacology, therapy and toxicology,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
June 2008,
The AAPS journal,
R Gandini, and
R Assereto, and
D Castoldi, and
E Cunietti, and
P Garanzelli, and
W Monzani
May 1974,
Acta pharmaceutica Suecica,
